Author: Tori Marsh

If you’re over the age of 50, you may have started to experience some of these difficult menopause symptoms: hot flashes, fatigue, night sweats, osteoporosis…not fun. Luckily, there are medications that can help you through menopause. But, are they affordable? One of the more commonly prescribed estrogens to treat menopausal symptoms and to prevent osteoporosis… Read More

Finally, some good news. This past October, amid efforts by the Trump administration aimed at improving drug price transparency, prices for some popular drugs dropped drastically. According to the GoodRx Index, drug manufacturer Merck reduced the list price for Zepatier by 60% and six other drugs by around 10% each. The GoodRx Index also showed… Read More

Flu season is officially underway, which means it’s time to get vaccinated. Flu shots can range from $0 (yes, free) to $50 or more, depending on where you get your shot and what kind of vaccine you receive. Whether you’re insured or not, there are ways to make your vaccines affordable. Here are some things… Read More

Over the past year, both Cialis and Viagra went generic, making erectile dysfunction (ED) drugs less expensive. This got us wondering, as more men are able to afford their ED drugs, which states are filling the most prescriptions for them? As it turns out, since January 2018, 0.24% of all prescription fills nationwide have been… Read More

GoodRx has completed the largest library of brand-drug savings programs on the internet, featuring over 800 manufacturer discount programs and 1,300 patient assistance programs for more than 1,600 drugs.* This database, which took more than five years of research and development, includes discounts made available by dozens of drug manufacturers, and offers savings for both… Read More

Even as US health officials set their sights on eradicating HIV, fills for the revolutionary HIV prevention drug Truvada have sharply declined since 2015 as patients face surging prices, poor coverage, insurance biases and skeptical doctors.     Introduced in 2012, Truvada for PrEP (pre-exposure prophylaxis) is a mixture of two medications, emtricitabine and tenofovir,… Read More

Another month, another round of price increases. This September, six popular drugs saw substantial price increases, by as much as 9.8% in some cases. The GoodRx Index also featured the following trends in the month of September: Flu season is starting. Prescription fills for popular cold and flu medications surged in September. , used to… Read More

Back in March 2018, manufacturer Teva Pharmaceuticals discontinued sales of the popular asthma inhaler Qvar, and released a new device known as the Qvar RediHaler. Some claim that RediHaler is easier to use with a new spacer-free design and breath-actuated inhalation, but others argue that this rebranding was a way for Teva to hold onto… Read More

You’re not imagining things—you really are paying more for your healthcare. In fact, employees are taking on an ever larger share of their medical costs, according to a new report released by Kaiser Family Foundation. In 2018, premiums and deductibles increased faster than wages, and nearly 50% of those covered by their employers pay high… Read More

pills stacked on coins

Treatments for hepatitis C are notoriously expensive, and the price for Harvoni is no different. Patients typically take Harvoni for 12 weeks, and the list price for a one-month supply runs at $31,500 for 28 tablets—or $1,125 per tablet—making Harvoni the ninth most expensive drug in the United States. We’re not kidding. Harvoni’s manufacturer, Gilead,… Read More